In order to understand the causes of infertility and the role modern infertility treatment plays in assisting conception, it is useful to look at the natural process - a woman's ovulatory cycle and the production of sperm in the male - and the hormones that play a major role in those processes. The gonadotropins are hormones that primarily affect the ovaries and the testes. They regulate the development and hormonesecreting functions of these organs and contribute to the production of sperm in the male and to the development and maturation of eggs (oocytes) in the female. Three gonadotropins are essential to reproduction: human follicle stimulating hormone (hFSH), human luteinizing hormone (hLH) and human chorionic gonadotropin (hCG). FSH and LH are secreted by the pituitary gland situated beneath the brain. Their secretion is controlled by another hormone, the gonadotropin- releasing hormone (GnRH) produced by the hypothalamus. hCG is primarily produced by the placenta following successful mplantation, and plays a role in maintaining pregnancy.
Autoimmunity is an immune responses of an human organism against its own cells and tissues. This aberrant immune response results in many different disease. These diseases are called autoimmune disease. Examples include Celiac disease, diabetes mellitus type 1, Sarcoidosis, systemic lupus erythematosus (SLE), Sjögren's syndrome, Churg-Strauss Syndrome, Hashimoto's thyroiditis, Graves' disease, idiopathic thrombocytopenic purpura, Addison's Disease, rheumatoid arthritis (RA), Polymyositis (PM), and Dermatomyositis (DM).
Diagnosis of autoimmune disorders largely rests on accurate history and physical examination of the patient . In several systemic disorders, serological assays which can detect specific autoantibodies are employed: Autoantibodies are used to diagnose many autoimmune diseases and their levels are measured to determine the progress of the disease.
The actual growth in testing volumes – as appearance of autoimmune disorders is increasing steadily - will prompt clinical laboratories to employ advanced autoimmune disease diagnostic tests. Several autoimmune disease diagnostic tests however are designed for manual operation and the shortage of skilled technicians limits their use. This creates immense demand for automated diagnostic platforms that facilitate rapid and efficient testing.
The constant increase in new diagnostics parameters for autoimmune diseases, the evolution of clinical laboratory demands have led to the development of a complete new range of Auto-Immunity diagnostics kits. DIAsource brings to market a totally new approach of auto-immune testing based on the latest state-of-the-art membrane technology (DOT). This DOT-technology combines simplicity and extraordinary clinical reliability with the possible identification of several autoantibodies in one single test. Together with a dedicated automated instrument, DIAsource Neptune, the diagnosis of auto-immune can be simplified and fully automated.
30 years of experience in IVD (kits and instrumentation)
DIAsource ImmunoAssays (formerly BioSource), an international diagnostic company based in Belgium, develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases.
We are committed to Vitamin D, including IVD and RUO Products. Our panel of assays allows the performant detection and measurement of various forms of Vitamin D metabolites : 25OH Vitamin D, 1,25(OH)2 Vitamin D.
Constantly looking for new technologies and applications, we put our expertise in the development of new antibodies and assays to measure relevant biomarkers. We are strengthening our position in the diagnostic market by validating our ELISA assays on our open automate. These innovation mark a turning point for our company, and makes of DIAsource, already renowned in the RIA market, a complete diagnostic provider.
We also provide selected instrumentation : we offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping our customers to automate their tests.
Present in more than 75 countries through his professional network of 80 distributors, DIAsource also sells directly his own products and products from other selected manufacturers to IVD laboratories in some European countries.
Effective 1 September 2017, DIAsource ImmunoAssays SA, the Belgian-based company specializing in development, sales and distribution of clinical diagnostics products, acquired the full assets of Viro-Immun Diagnostics GmbH, the German company specialized since 30 years in the development and manufacture of laboratory diagnostics for medical diagnosis of infectious and autoimmune diseases. For more information, please read our press release : English version - German Version - French version
Effective 5 September 2017, Biovendor – Laboratorní medicína a.s. (BioVendor) acquired 100% of the shares of DIAsource ImmunoAssays SA from the Australian stock listed company Anteo Diagnostics (ASX: ADO). Anteo Diagnostics had acquired DIAsource in January 2016. For more information, please read our press release.